Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

18 May 2023 10:23

RNS Number : 8917Z
Mandarin Oriental International Ltd
18 May 2023
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

18th May 2023 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2023.

 

The Group recorded an underlying profit in the first quarter of 2023, driven by improved performance from both the Group's owned hotels and its management business. RevPAR grew substantially in Asia compared to last year, as the region benefitted from the removal of travel restrictions. As a result, the Group's owned hotels saw a significantly improved performance, particularly in Hong Kong, Tokyo, and Bangkok. In the rest of the world, our hotels were also able to achieve a higher RevPAR compared to both last year and 2019, driven by strong rates.

 

The first quarter saw progress on a number of hotel developments. In January, the Group announced a new management contract for a luxury beach resort in Mallorca, Spain, scheduled to open by the end of 2024. In February, after three years' work, the Emirates Palace hotel in Abu Dhabi was rebranded as Emirates Palace Mandarin Oriental, Abu Dhabi. In March, Mandarin Oriental, Singapore, closed for a substantial renovation; it is expected to reopen in September 2023.

 

As a result of improved trading conditions, the Group generated underlying earnings before interest, tax, depreciation, and amortisation ('EBITDA') of US$30 million, a substantial increase from the EBITDA loss of US$1 million in the first quarter of 2022. Owned hotels reported an EBITDA of US$19 million, with almost all hotels delivering increased financial performance. The management business saw significant growth and generated higher fees, with hotels, particularly in Hong Kong and Mainland China, contributing to an EBITDA of US$7 million. Unaudited underlying profit in the first quarter was US$3 million, much improved from an underlying loss of US$26 million in 2022.

 

The Group's redevelopment project in Causeway Bay, Hong Kong, formerly the site of The Excelsior hotel, is ongoing, in line with our budget, and is expected to complete in early 2025.

 

Consolidated net debt as at 31st March 2023 reduced to US$311 million (US$376 million at 31st December 2022). The Group's liquidity position remains robust, with US$453 million in available committed debt facilities and US$306 million of cash reserves. Gearing was 6% of adjusted shareholders' funds.

 

On 2nd May 2023, the Company announced that Laurent Kleitman would replace James Riley as Group Chief Executive of Mandarin Oriental International Limited with effect from 1st September 2023.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

 

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKVLBFXELLBBB
Date   Source Headline
2nd Mar 202310:27 amRNSAudit Committee Chairman and Membership Changes
2nd Mar 20239:30 amRNSMandarin Oriental - 2022 Preliminary Results
31st Jan 202310:49 amRNSTotal Voting Rights
10th Nov 20229:42 amRNSInterim Management Statement
26th Sep 202210:21 amRNSBlock listing Interim Review
28th Jul 202210:28 amRNSHalf Year Results
18th Jul 20225:19 pmRNSMO announces Sale of MO, Washington D.C.
19th May 202210:27 amRNSInterim Management Statement
5th May 202212:40 pmRNSResult of AGM
7th Apr 202210:35 amRNSAnnual Financial Report
31st Mar 202211:34 amRNSTotal Voting Rights
25th Mar 20229:28 amRNSBlock listing Interim Review
3rd Mar 20229:29 amRNS2021 Preliminary Announcement of Results
31st Jan 20227:18 amRNSTotal Voting Rights
31st Dec 20217:01 amRNSTotal Voting Rights
30th Nov 20219:43 amRNSTotal Voting Rights
19th Nov 20219:28 amRNSDirectorate Change
11th Nov 20219:41 amRNSInterim Management Statement
22nd Oct 202110:18 amRNSDirectorate Change
27th Sep 202110:23 amRNSBlock listing Interim Review
30th Jul 202110:20 amRNSTotal Voting Rights
29th Jul 202110:38 amRNSDirectorate Change
29th Jul 202110:23 amRNS2021 HALF YEAR FINANCIAL STATEMENTS
30th Jun 202110:21 amRNSTotal Voting Rights
1st Jun 20217:02 amRNSTotal Voting Rights
20th May 20217:00 amRNSDirectorate Change
5th May 20211:25 pmRNSResult of AGM
5th May 202110:24 amRNSInterim Management Statement
30th Apr 202110:30 amRNSTotal Voting Rights
16th Apr 202110:26 amRNSHolding(s) in Company
8th Apr 202110:31 amRNSAnnual Financial Report
25th Mar 20219:27 amRNSBlock listing Interim Review
24th Mar 20219:47 amRNSDirector Declaration
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
3rd Dec 202012:30 pmRNSDirectorate Change
5th Nov 20209:27 amRNSInterim Management Statement
27th Oct 20209:27 amRNSDirectorate Change
27th Oct 20209:21 amRNSDirectorate Change
25th Sep 202010:50 amRNSBlock listing Interim Review
25th Sep 202010:47 amRNSDirector/PDMR Shareholding
30th Jul 202011:01 amRNSHalf-year Report
15th Jun 202010:22 amRNSDirector Declaration
29th May 202010:20 amRNSTotal Voting Rights
6th May 20201:13 pmRNSNon-Routine Resolutions submitted via NSM
6th May 20201:07 pmRNSResult of AGM
9th Apr 202010:21 amRNSInterim Management Statement
9th Apr 20207:38 amRNSAdditional Listing
7th Apr 202010:30 amRNSAnnual Financial Report
30th Mar 202011:07 amRNSDirector Declaration
25th Mar 20209:27 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.